Treatment barriers among individuals with co-occurring substance use and mental health problems: Examining gender differences.

Co-occurring disorders Gender differences Mental health disorders Stigma Substance use disorders Treatment barriers

Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
05 2020
Historique:
received: 07 08 2019
revised: 14 01 2020
accepted: 16 01 2020
entrez: 23 3 2020
pubmed: 23 3 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Despite the narrowing gender gap in the prevalence of substance use disorders, women continue to be vastly underrepresented in substance use services. Relational factors, family responsibilities, mental health, and stigma may present unique barriers encountered by women. The aims of this study were to examine: (1) gender differences in substance use treatment barriers, (2) gender differences in perceptions of stigmatization for seeking substance use treatment, and symptoms of depression, anxiety, and trauma-related stress, and (3) whether perceived stigmatization and mental health symptoms are associated with greater barriers among women. One hundred adults (50% self-identified women) from a substance use and concurrent disorders program in Ontario, Canada, completed a questionnaire package containing measures of sociodemographic information, substance use, mental health, perceived stigma, and substance use treatment barriers. Women reported more barriers related to family responsibilities, relational factors, and mental health (p < .01), and higher levels of perceived stigma (p < .01) compared to men. Findings from this study contribute to our understanding of treatment barriers and perceived stigmatization among women. This knowledge may be used to aid in the development and delivery of accessible, gender-responsive services that address these barriers and challenge the stigma attached to substance use among women.

Sections du résumé

BACKGROUND
Despite the narrowing gender gap in the prevalence of substance use disorders, women continue to be vastly underrepresented in substance use services. Relational factors, family responsibilities, mental health, and stigma may present unique barriers encountered by women.
AIMS
The aims of this study were to examine: (1) gender differences in substance use treatment barriers, (2) gender differences in perceptions of stigmatization for seeking substance use treatment, and symptoms of depression, anxiety, and trauma-related stress, and (3) whether perceived stigmatization and mental health symptoms are associated with greater barriers among women.
METHODS
One hundred adults (50% self-identified women) from a substance use and concurrent disorders program in Ontario, Canada, completed a questionnaire package containing measures of sociodemographic information, substance use, mental health, perceived stigma, and substance use treatment barriers.
RESULTS
Women reported more barriers related to family responsibilities, relational factors, and mental health (p < .01), and higher levels of perceived stigma (p < .01) compared to men.
CONCLUSIONS
Findings from this study contribute to our understanding of treatment barriers and perceived stigmatization among women. This knowledge may be used to aid in the development and delivery of accessible, gender-responsive services that address these barriers and challenge the stigma attached to substance use among women.

Identifiants

pubmed: 32199543
pii: S0740-5472(19)30443-X
doi: 10.1016/j.jsat.2020.01.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-35

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None to declare.

Auteurs

Silvana Agterberg (S)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave, Bronx, NY 10461, United States of America. Electronic address: sagterbe@mail.yu.edu.

Nicholas Schubert (N)

The Royal Ottawa Mental Health Centre, Substance Use and Concurrent Disorders Program, 1145 Carling Ave., Ottawa, ON K1Z 7K4, Canada. Electronic address: nickschubert99@gmail.com.

Louise Overington (L)

The Royal Ottawa Mental Health Centre, Substance Use and Concurrent Disorders Program, 1145 Carling Ave., Ottawa, ON K1Z 7K4, Canada; The Royal's Institute of Mental Health Research, 1145 Carling Ave., Ottawa, ON K1Z 7K4, Canada. Electronic address: louise.overington@mail.mcgill.ca.

Kimberly Corace (K)

The Royal Ottawa Mental Health Centre, Substance Use and Concurrent Disorders Program, 1145 Carling Ave., Ottawa, ON K1Z 7K4, Canada; The Royal's Institute of Mental Health Research, 1145 Carling Ave., Ottawa, ON K1Z 7K4, Canada; Faculty of Medicine, Department of Psychiatry, University of Ottawa, 5457-1145 Carling Avenue, Ottawa, ON K1Z 7K4, Canada. Electronic address: kim.corace@theroyal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH